Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).

Abstract:

:MicroRNAs (miRNAs) are small non-coding, endogenous, single-stranded RNAs. MiRNAs have been implicated in different areas such as the immune response, neural development, DNA repair, apoptosis, oxidative stress response and cancer. However, while the majority of miRNAs are found intracellularly, a significant number of miRNAs have been observed outside of cells, including various body fluids. Circulating miRNAs function as 'extracellular communication RNAs' that play an important role in cell proliferation and differentiation. MiRNA regulation is essential to many cellular processes, and escape from this regulatory network seems to be a common characteristic of several disease processes and malignant transformation. The interest in circulating miRNAs reflects in fact their central role in regulation of gene expression and the implication of miRNA-specific aberrant expression in the pathogenesis of cancer, cardiac, metabolic, neurologic, immune-related diseases as well as others. In our review we aimed to summarize the data related to the action of cellular miRNAs on the onset of various diseases, thus bringing together some of the latest information available on the role of circulating miRNAs. Additionally, the role of circulating miRNAs could be particularly relevant in the context of neoplastic diseases. At least 79 miRNAs have been reported as plasma or serum miRNA biomarkers of solid and hematologic tumors. Circulating miRNA profiling could improve the diagnosis of cancer, and could predict outcome for cancer patients, while the profiling of alterations in circulating miRNA that may signal a predisposition to cancer, could also be a therapeutic target in these patients.

journal_name

Int J Oncol

authors

Allegra A,Alonci A,Campo S,Penna G,Petrungaro A,Gerace D,Musolino C

doi

10.3892/ijo.2012.1647

subject

Has Abstract

pub_date

2012-12-01 00:00:00

pages

1897-912

issue

6

eissn

1019-6439

issn

1791-2423

journal_volume

41

pub_type

杂志文章,评审
  • Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.

    abstract::Hepatocyte growth factor (HGF), the ligand for the c-met proto-oncogene product, is a multifunctional protein that enhances tumor cell motility, extracellular matrix invasion, and mitogenic or morphogenic activities of various cell types. In this study we examined the expression of the c-Met receptor in human oral squ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Murai M,Shen X,Huang L,Carpenter WM,Lin CS,Silverman S,Regezi J,Kramer RH

    更新日期:2004-10-01 00:00:00

  • Induced overexpression of CD44 associated with resistance to apoptosis on DNA damage response in human head and neck squamous cell carcinoma cells.

    abstract::CD44 is a marker of cancer stem cells in head and neck squamous cell carcinoma, and CD44 expression is related to prognosis in cancer patients. We examined whether herbal medicine components affect CD44 expression and induce cancer cell apoptosis. Baicalin enhanced apoptosis with no effect on CD44 levels, while baical...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2016.3821

    authors: Ohkoshi E,Umemura N

    更新日期:2017-02-01 00:00:00

  • Tumor-necrosis-factor and DNA topoisomerase-ii inhibitors in human ovarian-cancer - potential role in chemotherapy.

    abstract::Seven ovarian and one cervical human cancer cell lines were examined far their sensitivity or resistance to tumor necrosis factor, to three topoisomerase II inhibitors and to cisplatin. Only one line exhibited the multidrug-resistance phenotype and another one an 'atypical'-MDR phenotype. The combination of TNF and to...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Aluigi M,Debernardis D,Cimoli G,Ottoboni C,Parodi S,Russo P

    更新日期:1995-09-01 00:00:00

  • Methodological approach to study the genomic profile of the human breast.

    abstract::One of the key end-points for understanding the molecular basis of the breast in its normal and cancer status is the quantitation of gene expression in specific cell populations. Microdissection techniques allow extraction of morphologically distinct cells for molecular analysis. The objective of this study was to det...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Balogh GA,Heulings R,Mailo D,Wang R,Li YS,Hardy R,Russo J

    更新日期:2007-08-01 00:00:00

  • GAS64, the first amplified and putative non-translated gene.

    abstract::Gene amplification occurs frequently in human glioblastomas. We report the amplification and expression analysis of glioma amplified sequence 64 (GAS64) which was recently identified by microdissection mediated cDNA capture from the amplicon at 12q13-15. Herein we analyzed primary tumor tissues for amplification frequ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Fischer U,Schütz N,Hemmer D,Meese E

    更新日期:2002-01-01 00:00:00

  • Peritoneal myofibroblasts at metastatic foci promote dissemination of pancreatic cancer.

    abstract::Myofibroblasts in the stroma of pancreatic cancers promote tumor proliferation, invasion and metastasis by increasing extracellular matrix and secretion of several growth factors. In contrast, the role of myofibroblasts at peritoneally disseminated sites of pancreatic cancer has not yet been determined. This study was...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2391

    authors: Akagawa S,Ohuchida K,Torata N,Hattori M,Eguchi D,Fujiwara K,Kozono S,Cui L,Ikenaga N,Ohtsuka T,Aishima S,Mizumoto K,Oda Y,Tanaka M

    更新日期:2014-07-01 00:00:00

  • Expression profile‑driven discovery of AURKA as a treatment target for liposarcoma.

    abstract::Liposarcoma (LPS) is one of the most frequently reported type of soft‑tissue sarcoma (STS). Well‑differentiated (WD) LPS and dedifferentiated (DD) LPS are the two most common subtypes. Chemotherapy has been considered to be ineffective in LPS, and novel treatment agents are thus necessary. In this study, we reanalyzed...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2019.4861

    authors: Yen CC,Chen SC,Hung GY,Wu PK,Chua WY,Lin YC,Yen CH,Chen YC,Wang JY,Yang MH,Chao Y,Chang MC,Chen WM

    更新日期:2019-10-01 00:00:00

  • ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation.

    abstract::A disintegrin and metalloproteinase-17 (ADAM17) can cut and release a wide variety of epidermal growth factor receptor (EGFR) ligands to promote survival, invasion and proliferation of cancer cell, and therefore, is considered to be a potential therapeutic target for cancer. The main goal of the present study was to o...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2016.3536

    authors: Meng X,Hu B,Hossain MM,Chen G,Sun Y,Zhang X

    更新日期:2016-08-01 00:00:00

  • Low incidence of genetic alterations of the p16CDKN2a in clear cell chondrosarcoma.

    abstract::Mutational inactivation of the cyclin-dependent kinase inhibitors (CDKIs) (p16CDKN2a) tumor suppressor gene has been found in a variety of human tumor types. To investigate the involvement of CDKI abnormality in clear cell chondrosarcoma, alterations of CDKIs were examined in clear cell chondrosarcoma tissues using a ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.19.4.749

    authors: Park YK,Cho CH,Chi SG,Han CS,Ushigome S,Unni KK

    更新日期:2001-10-01 00:00:00

  • Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells.

    abstract::Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer related deaths in men in the United States. Ciprofloxacin is a relatively non-toxic antibiotic that can be easily administered orally with large volume of distribution and good tissue penetration. Studies from others and our l...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: El-Rayes BF,Grignon R,Aslam N,Aranha O,Sarkar FH

    更新日期:2002-07-01 00:00:00

  • Endosialin: a novel malignant cell therapeutic target for neuroblastoma.

    abstract::Endosialin emerged recently as a potential therapeutic target for sarcoma. Since some sarcoma subtypes, such as Ewing's sarcoma, show characteristics of neuroendocrine differentiation, we wondered whether cancers with neuro-endocrine properties and/or neuroectodermal origin, such as neuroblastoma, small cell lung canc...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.1091

    authors: Rouleau C,Smale R,Sancho J,Fu YS,Kurtzberg L,Weber W,Kruger A,Jones C,Roth S,Bormann C,Dunham S,Krumbholz R,Curiel M,Wallar G,Mascarello J,Campos-Rivera J,Horten B,Schmid S,Miller G,Teicher BA

    更新日期:2011-10-01 00:00:00

  • Inositol hexaphosphate limits the migration and the invasiveness of colorectal carcinoma cells in vitro.

    abstract::Inositol hexaphosphate (IP6), also known as phytic acid, has been shown to exhibit anticancer effects in a number of preclinical tumor models. IP6 decreases proliferation by arresting cells in the G0/G1 phase, inhibits iron-mediated oxidative reactions, enhances differentiation and stimulates apoptosis. The present st...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2018.4488

    authors: Schröterová L,Ježková A,Rudolf E,Caltová K,Králová V,Hanušová V

    更新日期:2018-10-01 00:00:00

  • Ras and p53 expression in non-small-cell lung-cancer patients - p53 over-expression correlates with a poor prognosis.

    abstract::Expression of the tumor suppressor gene p53 and the ras oncogene were examined in 46 tumor and nodal specimens of non-small cell lung cancer (NSCLC) using the antibodies p53 pAb 240 and ras Y13-259 respectively. p53 expression was elevated in 46% and ras p21 was over-expressed in 85% of the tumor specimens analyzed. F...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.1.4.403

    authors: Papadakis E,Malliri A,Linardopoulos S,Karaiossifidi H,Field J,Spandidos D

    更新日期:1992-09-01 00:00:00

  • Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells.

    abstract::Developing simple and effective approaches to detect tumor markers will be critical for early diagnosis or prognostic evaluation of prostate cancer treatment. Prostate‑specific membrane antigen (PSMA) has been validated as an important tumor marker for prostate cancer progression including angiogenesis and metastasis....

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2256

    authors: Liu T,Mendes DE,Berkman CE

    更新日期:2014-03-01 00:00:00

  • Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice.

    abstract::Acute lymphoblastic leukemia (ALL) with translocation t(4;11) is a high-risk leukemia found in 60-85% of infants with ALL and is often refractory to conventional chemotherapeutics after relapse. To evaluate the efficacy of dietary resveratrol in vivo, 5-week-old NOD.CB17-Prkdcscid/J mice were fed a control diet or a d...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2012.1650

    authors: Zunino SJ,Storms DH,Newman JW,Pedersen TL,Keen CL,Ducore JM

    更新日期:2012-12-01 00:00:00

  • Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.

    abstract::Signal transducers and activators of transcription 3 (STAT3) signaling is persistently activated in many types of cancer cells, and represents a valid target for anticancer drug design. However, few reports have described the constitutive activation of STAT3 in human sarcoma cells. In this study, we demonstrate that t...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Wei CC,Ball S,Lin L,Liu A,Fuchs JR,Li PK,Li C,Lin J

    更新日期:2011-01-01 00:00:00

  • Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo.

    abstract::We examined the expression levels of P-glycoprotein (P-Gp)/the human multidrug resistance gene (MDR1) and in vivo chemosensitivity in the 7 osteosarcoma xenografts. Three of seven (43%) osteosarcoma xenografts expressed MDR1 by reverse transcriptase-polymerase chain reaction (RT-PCR). The OSS-516R xenograft selected w...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Suto R,Abe Y,Nakamura M,Ohnishi Y,Yoshimura M,Lee YH,Imanishi T,Yamazaki H,Kijima H,Tokunaga T,Oshika Y,Hiraoka N,Tamaoki N,Fukuda H,Ueyama Y

    更新日期:1998-02-01 00:00:00

  • Immunotherapy of breast cancer by single delivery with rAAV2-mediated interleukin-15 expression.

    abstract::Recombinant adenovirus-associated vector serotype 2 (rAAV2) is one of the most promising gene transfer vectors due to its advantage of causing non-pathogenic infection, low immunogenicity, and long-term gene expression in human clinical trials. Human interleukin 15 (hIL15) has been implicated in modulation of antitumo...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Yu YL,Wei CW,Chen YL,Chen MH,Yiang GT

    更新日期:2010-02-01 00:00:00

  • Pyrogallol induces the death of human pulmonary fibroblast cells through ROS increase and GSH depletion.

    abstract::Pyrogallol (PG) inhibits the growth of various cells via stimulating O2•--mediated death. This study investigated the effects of PG on cell death in human pulmonary fibroblast (HPF) cells in relation to reactive oxygen species (ROS) and glutathione (GSH) levels. PG inhibited the growth of HPF cells with an IC50 of ~50...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2016.3543

    authors: Park WH

    更新日期:2016-08-01 00:00:00

  • Anti-angiogenic strategies for cancer therapy (Review).

    abstract::Acquired drug resistance to chemotherapy is a major problem in the treatment of cancer. After primary surgical intervention, followed by chemotherapy treatments, the majority of patients develop disease recurrence. This is due to tumor cell heterogeneity and genetic instability. In contrast to tumor cells, proliferati...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:

    authors: Benouchan M,Colombo BM

    更新日期:2005-08-01 00:00:00

  • Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood.

    abstract::Evidence from the literature widely supports the efficacy of screening for colorectal cancer (CRC) in reducing mortality. A blood-based assay, potentially, represents a more accessible early detection tool for the identification of circulating tumour cells originating from a primary tumour site in the body. The presen...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo_00000701

    authors: Lauriola M,Ugolini G,Rosati G,Zanotti S,Montroni I,Manaresi A,Zattoni D,Rivetti S,Mattei G,Coppola D,Strippoli P,Taffurelli M,Solmi R

    更新日期:2010-08-01 00:00:00

  • Bioflavonoids, type II [H-3]estradiol binding sites and prostatic cancer cell proliferation.

    abstract::Previous studies from this laboratory have shown that bioflavonoids including luteolin and quercetin possess antiestrogenic activity in the female reproductive tract and appear to elicit this activity by interaction with type II [H-3]estradiol binding sites in the cell nucleus. Studies by a number of laboratories incl...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.11.6.1311

    authors: Markaverich B,Alejandro M

    更新日期:1997-12-01 00:00:00

  • Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil.

    abstract::Chemokine-mediated activation of G protein-coupled receptors CXCR1/2 promotes tumor growth, invasion, inflammation and metastasis. Repertaxin, a CXCR1/2 small-molecule inhibitor, has been shown to attenuate many of these tumor-associated processes. The present study aimed to investigate the effects of repertaxin alone...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2016.3371

    authors: Wang J,Hu W,Wang K,Yu J,Luo B,Luo G,Wang W,Wang H,Li J,Wen J

    更新日期:2016-04-01 00:00:00

  • A murine model of hepatitis B-associated hepatocellular carcinoma generated by adeno-associated virus-mediated gene delivery.

    abstract::A relevant animal model is critical for investigating the pathogenic mechanisms underlying hepatitis B virus (HBV)-induced hepatocellular carcinoma (HCC). Mice are not naturally infected by HBV, presumably due to the lack of HBV receptors on mouse hepatocytes. To bypass this entry step of HBV infection, we report gene...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.1145

    authors: Huang YH,Fang CC,Tsuneyama K,Chou HY,Pan WY,Shih YM,Wu PY,Chen Y,Leung PS,Gershwin ME,Tao MH

    更新日期:2011-12-01 00:00:00

  • No microsatellite instability, but frequent LOH in liposarcomas.

    abstract::To evaluate the significance of microsatellite instability (MI) and loss of heterozygosity (LOH) in the development of different histological subgroups of liposarcomas, we examined 28 tissue-samples from 21 patients and the corresponding non-neoplastic reference tissues. We investigated nine microsatellite loci and de...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.14.4.721

    authors: Schneider-Stock R,Szibor R,Walter H,Plate I,Roessner A

    更新日期:1999-04-01 00:00:00

  • 2 gene families of mareks-disease virus (mdv) with a potential role in tumor-induction in chicken (review).

    abstract::Marek's disease virus (MDV) is one of the most oncogenic herpesviruses and the only cancer virus that has a successful vaccine. Based on the short-latency and polyclonal nature of the tumors, it is likely that MDV encodes its own oncogenes. Recent studies have provided insights into possible MDV genes involved in onco...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.6.5.997

    authors: Kung H,Tanaka A,Nonoyama M

    更新日期:1995-05-01 00:00:00

  • Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.

    abstract::Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is one of the most promising anti-cancer agents, but some tumor types develop resistance to TRAIL. Here, we report that chetomin, an inhibitor of hypoxia-inducible factors, is a potent enhancer of TRAIL-induced apoptosis. TRAIL or chetomin alone weakly in...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2010.874

    authors: Yano K,Horinaka M,Yoshida T,Yasuda T,Taniguchi H,Goda AE,Wakada M,Yoshikawa S,Nakamura T,Kawauchi A,Miki T,Sakai T

    更新日期:2011-02-01 00:00:00

  • Salinomycin causes migration and invasion of human fibrosarcoma cells by inducing MMP-2 expression via PI3-kinase, ERK-1/2 and p38 kinase pathways.

    abstract::Salinomycin (SAL) is a polyether ionophore antibiotic that has recently been shown to regulate a variety of cellular responses in various human cancer cells. However, the effects of SAL on metastatic capacity of HT1080 human fibrosarcoma cells have not been elucidated. We investigated the effect of SAL on migration an...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2016.3448

    authors: Yu SM,Kim SJ

    更新日期:2016-06-01 00:00:00

  • Polysaccharide-K augments docetaxel-induced tumor suppression and antitumor immune response in an immunocompetent murine model of human prostate cancer.

    abstract::Advanced castration-resistant prostate cancer has high mortality rates and limited treatment options. Novel therapies are needed to better contend with this disease. Polysaccharide-K® (PSK), an extract of the mushroom Trametes versicolor, has immunomodulatory and tumor suppressive a...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.1292

    authors: Wenner CA,Martzen MR,Lu H,Verneris MR,Wang H,Slaton JW

    更新日期:2012-04-01 00:00:00

  • Protein profiling of osteosarcoma tissue and soft callus unveils activation of the unfolded protein response pathway.

    abstract::Oncogenic drivers of osteosarcoma remain controversial due to the complexity of the genomic background of the disease. There are limited novel therapeutic options, and the survival rate of patients with osteosarcoma has not improved in decades. Genomic instability leads to complexity in various pathways, which is pote...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2019.4737

    authors: Chaiyawat P,Sungngam P,Teeyakasem P,Sirikaew N,Klangjorhor J,Settakorn J,Diskul-Na-Ayudthaya P,Chokchaichamnankit D,Srisomsap C,Svasti J,Pruksakorn D

    更新日期:2019-05-01 00:00:00